Advertisement
Canada markets open in 5 hours 16 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7331
    +0.0008 (+0.10%)
     
  • CRUDE OIL

    84.00
    +0.43 (+0.51%)
     
  • Bitcoin CAD

    87,815.75
    +509.92 (+0.58%)
     
  • CMC Crypto 200

    1,387.57
    -8.97 (-0.64%)
     
  • GOLD FUTURES

    2,360.10
    +17.60 (+0.75%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,759.50
    +192.00 (+1.09%)
     
  • VOLATILITY

    15.50
    +0.13 (+0.85%)
     
  • FTSE

    8,122.16
    +43.30 (+0.54%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Biosimilars Could Boost Amgen’s Revenue Growth

In September 2017, Amgen and Allergan presented results from the Phase 3 trial, which evaluated the safety and efficacy of ABP 980, a proposed biosimilar to Herceptin.